148 related articles for article (PubMed ID: 37084317)
1. Current status of pancreatic cancer with oligometastasis.
Chapa-Azuela Ó; Corona-Torres MJ; Ayala-Moreno EA; Arroyo-Paredes PS; Pérez-Torres E; Rodríguez-Báez A; Montalvo-Javé EE
Cir Cir; 2023; 91(2):262-267. PubMed ID: 37084317
[TBL] [Abstract][Full Text] [Related]
2. [A Case Report of Conversion Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastasis after Chemotherapy].
Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Kawai K; Inatome J; Murakami K; Naito A; Kagawa Y; Masuzawa T; Takeno A; Egawa C; Murata K
Gan To Kagaku Ryoho; 2019 Apr; 46(4):802-804. PubMed ID: 31164541
[TBL] [Abstract][Full Text] [Related]
3. [Oligometastasis in pancreatic cancer : Current state of knowledge and spectrum of local therapy].
Gebauer F; Damanakis AI; Bruns C
Chirurg; 2018 Jul; 89(7):510-515. PubMed ID: 29557488
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
Hamad A; Underhill J; Ansari A; Thayaparan V; Cloyd JM; Li Y; Pawlik TM; Tsung A; Abushahin L; Ejaz A
Surgery; 2022 Jun; 171(6):1464-1470. PubMed ID: 35115154
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature.
Sakaguchi T; Valente R; Tanaka K; Satoi S; Del Chiaro M
Pancreatology; 2019 Jul; 19(5):672-680. PubMed ID: 31285145
[TBL] [Abstract][Full Text] [Related]
6. Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma.
Yasuda S; Nagai M; Terai T; Kohara Y; Sho M
Ann Gastroenterol Surg; 2023 May; 7(3):358-366. PubMed ID: 37152775
[TBL] [Abstract][Full Text] [Related]
7. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
8. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
[TBL] [Abstract][Full Text] [Related]
9. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection of synchronous and metachronous metastases from pancreatic adenocarcinoma. Two case reports in the light of recent evidences.
Cannistra' M; Ruggiero M; Zullo A; Grande R; Nardo B
Ann Ital Chir; 2015 Dec; 86(ePub):S2239253X15024160. PubMed ID: 26754676
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1).
Wei M; Shi S; Hua J; Xu J; Yu X;
BMJ Open; 2019 Dec; 9(12):e033452. PubMed ID: 31818843
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant treatment of surgically resectable pancreatic ductal adenocarcinoma.
Tesfaye AA; Philip PA
Clin Adv Hematol Oncol; 2019 Jan; 17(1):54-63. PubMed ID: 30843899
[TBL] [Abstract][Full Text] [Related]
13. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
14. Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal papillary mucinous neoplasm: a case report.
Tamura K; Ohtsuka T; Ideno N; Aso T; Kono H; Nagayoshi Y; Shindo K; Ushijima Y; Ueda J; Takahata S; Ito T; Oda Y; Mizumoto K; Tanaka M
JOP; 2013 Jul; 14(4):450-3. PubMed ID: 23846946
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
16. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.
Soloff EV; Zaheer A; Meier J; Zins M; Tamm EP
Abdom Radiol (NY); 2018 Feb; 43(2):301-313. PubMed ID: 29198002
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous brain and lung metastases of pancreatic ductal adenocarcinoma after curative pancreatectomy: a case report and literature review.
Oka Y; Takano S; Kouchi Y; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Kagawa S; Hosokawa I; Mishima T; Konishi T; Kishimoto T; Ohtsuka M
BMC Gastroenterol; 2021 Jan; 21(1):9. PubMed ID: 33407200
[TBL] [Abstract][Full Text] [Related]
18. "Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer.
Lombardi P; Silvestri S; Marino D; Santarelli M; Campra D; De Paolis P; Aglietta M; Leone F;
Crit Rev Oncol Hematol; 2019 Jan; 133():17-24. PubMed ID: 30661653
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Kaufmann B; Hartmann D; D'Haese JG; Stupakov P; Radenkovic D; Gloor B; Friess H
Dig Surg; 2019; 36(6):455-461. PubMed ID: 30408790
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival after repeated resection of metachronous lung metastases from pStage IA pancreatic adenocarcinoma.
Miyasaka M; Noji T; Ohtaka K; Chiba R; Sato S; Shoji Y; Hase R; Ichimura T; Hirano S; Senmaru N
Clin J Gastroenterol; 2018 Feb; 11(1):53-61. PubMed ID: 29039114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
